Activity Overview
This educational activity is an archive of the live conference held on July 11 – 12, 2026.
Target Audience
This educational activity is directed toward hematologists, medical oncologists, and fellows involved in the treatment and management of patients with hematologic malignancies. Nurse practitioners, nurses, physician assistants, pharmacists, researchers, and other health care professionals interested in the treatment of hematologic malignancies may also participate.
Learning Objectives
- Select appropriate initial therapy using clinical evidence, guidelines, and patient- and disease-specific factors (including biomarkers)
Barbara Pro, MD
Professor of Medicine, Division of Hematology
and Oncology
Columbia University Vagelos College of
Physicians and Surgeons
Clinical Director, Lymphoma Program
Herbert Irving Comprehensive Cancer Center
NewYork-Presbyterian/Columbia University
Irving Medical Center
New York, NY
Joshua Brody, MD
Director, Lymphoma Immunotherapy Program
The Leon and Norma Hess Center for Science
and Medicine
Icahn School of Medicine at Mount Sinai
New York, NY
Hua-Jay “Jeff” Cherng, MD
Assistant Professor of Medicine
Columbia University Irving Medical Center
New York, NY
Brandon DaSilva, MD
Clinical Fellow
Columbia University Irving Medical Center
New York, NY
Patrick Gould, MD
Hematology and Oncology Fellow
Memorial Sloan Kettering Cancer Center
New York, NY
Prashant Kapoor, MD, FACP
Hematologist / Oncologist
Mayo Clinic Comprehensive Cancer Center
Rochester, MN
Please click here to view disclosures for faculty and the staff of Physicians’ Education Resource®.
GET STARTED WITH THIS PROGRAM:
Register now to gain access to this program.
Create AccountAlready Registered? Login Here
